DE60027601D1 - Arzneizubereitung mit kontrollierter freisetzung enthaltend tramadol hydrochlorid - Google Patents

Arzneizubereitung mit kontrollierter freisetzung enthaltend tramadol hydrochlorid

Info

Publication number
DE60027601D1
DE60027601D1 DE60027601T DE60027601T DE60027601D1 DE 60027601 D1 DE60027601 D1 DE 60027601D1 DE 60027601 T DE60027601 T DE 60027601T DE 60027601 T DE60027601 T DE 60027601T DE 60027601 D1 DE60027601 D1 DE 60027601D1
Authority
DE
Germany
Prior art keywords
controlled release
tramadol hydrochloride
containing tramadol
drug preparation
release containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60027601T
Other languages
English (en)
Other versions
DE60027601T2 (de
Inventor
L Uboslav Razus
Helena Sedlarov
Ivan Varga
Ondrej Gattnar
Marian Zemanek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zentiva KS
Original Assignee
Zentiva KS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentiva KS filed Critical Zentiva KS
Application granted granted Critical
Publication of DE60027601D1 publication Critical patent/DE60027601D1/de
Publication of DE60027601T2 publication Critical patent/DE60027601T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60027601T 1999-12-28 2000-12-20 Arzneizubereitung mit kontrollierter freisetzung enthaltend tramadol hydrochlorid Expired - Fee Related DE60027601T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SK1868-99A SK285128B6 (sk) 1999-12-28 1999-12-28 Liečivý prípravok s riadeným uvoľňovaním obsahujúci tramadol hydrochlorid a spôsob jeho prípravy
SK186899 1999-12-28
PCT/SK2000/000027 WO2001047497A2 (en) 1999-12-28 2000-12-20 Controlled release pharmaceutical composition containing tramadol hydrochloride

Publications (2)

Publication Number Publication Date
DE60027601D1 true DE60027601D1 (de) 2006-06-01
DE60027601T2 DE60027601T2 (de) 2007-04-26

Family

ID=20434830

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60027601T Expired - Fee Related DE60027601T2 (de) 1999-12-28 2000-12-20 Arzneizubereitung mit kontrollierter freisetzung enthaltend tramadol hydrochlorid

Country Status (25)

Country Link
US (1) US20030175343A1 (de)
EP (1) EP1255535B1 (de)
JP (1) JP2003518486A (de)
AT (1) ATE324103T1 (de)
AU (1) AU2421601A (de)
BG (1) BG65713B1 (de)
CA (1) CA2397942C (de)
CY (1) CY1106127T1 (de)
CZ (1) CZ297394B6 (de)
DE (1) DE60027601T2 (de)
DK (1) DK1255535T3 (de)
EA (1) EA006438B1 (de)
EE (1) EE05231B1 (de)
ES (1) ES2266018T3 (de)
GE (1) GEP20053532B (de)
HU (1) HUP0203842A3 (de)
LT (1) LT5033B (de)
LV (1) LV12917B (de)
PL (1) PL208096B1 (de)
PT (1) PT1255535E (de)
SI (1) SI1255535T1 (de)
SK (1) SK285128B6 (de)
TW (1) TWI221419B (de)
UA (1) UA76411C2 (de)
WO (1) WO2001047497A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8128957B1 (en) 2002-02-21 2012-03-06 Valeant International (Barbados) Srl Modified release compositions of at least one form of tramadol
US20050182056A9 (en) * 2002-02-21 2005-08-18 Seth Pawan Modified release formulations of at least one form of tramadol
SK286107B6 (sk) * 2002-04-12 2008-03-05 Zentiva, A. S. Analgeticky účinný perorálny liečivý prípravok s kontrolovaným uvoľňovaním opioidnej účinnej látky a spôsob jeho prípravy
DE10245623A1 (de) * 2002-09-30 2004-04-08 Clariant Gmbh Ester und Partialester aus mehrwertigen Alkoholen
WO2005004900A1 (en) * 2003-07-11 2005-01-20 Novartis Ag Orally dosed pharmaceutical compositions comprising a delivery agent in micronized form
US20100143573A1 (en) * 2006-06-09 2010-06-10 John Godber Mineral fortification substance for clear beverages
WO2007146184A2 (en) * 2006-06-09 2007-12-21 Innophos, Inc. Calcium fortification substance for clear beverages
DE102006044694A1 (de) * 2006-09-22 2008-03-27 Krewel Meuselbach Gmbh Perorale feste Schmerzmittelzubereitung
US20100003322A1 (en) * 2008-07-03 2010-01-07 Lai Felix S Enteric coated hydrophobic matrix formulation
WO2014078435A1 (en) 2012-11-14 2014-05-22 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ260408A (en) * 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
DE4329794C2 (de) * 1993-09-03 1997-09-18 Gruenenthal Gmbh Tramadolsalz enthaltende Arzneimittel mit verzögerter Wirkstofffreisetzung
ES2168290T3 (es) 1993-11-23 2002-06-16 Euro Celtique Sa Metodo para preparar una composicion de liberacion sostenida.
DE4343993A1 (de) * 1993-12-22 1995-06-29 Stockhausen Chem Fab Gmbh Pfropf-Copolymerisate von ungesättigten Monomeren und Polyhydroxyverbindungen, Verfahren zu ihrer Herstellung und ihre Verwendung
FR2753904B1 (fr) * 1996-10-01 1998-10-30 Gattefosse Ets Sa Composition pharmaceutique a liberation modifiee de principe actif, comportant une matrice, et procede de fabrication
US5980941A (en) * 1997-08-20 1999-11-09 Fuisz Technologies Ltd. Self-binding shearform compositions
DE19901683B4 (de) * 1999-01-18 2005-07-21 Grünenthal GmbH Analgetikum mit kontrollierter Wirkstofffreisetzung
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions

Also Published As

Publication number Publication date
SK285128B6 (sk) 2006-07-07
WO2001047497A2 (en) 2001-07-05
ATE324103T1 (de) 2006-05-15
EP1255535B1 (de) 2006-04-26
CZ20022371A3 (cs) 2002-10-16
US20030175343A1 (en) 2003-09-18
DE60027601T2 (de) 2007-04-26
TWI221419B (en) 2004-10-01
EE05231B1 (et) 2009-12-15
HUP0203842A2 (hu) 2003-05-28
WO2001047497A3 (en) 2002-09-12
LT2002078A (en) 2003-03-25
LV12917B (en) 2003-02-20
ES2266018T3 (es) 2007-03-01
EA006438B1 (ru) 2005-12-29
CZ297394B6 (cs) 2006-12-13
SK186899A3 (en) 2001-07-10
SI1255535T1 (sl) 2006-10-31
HUP0203842A3 (en) 2004-06-28
EP1255535A2 (de) 2002-11-13
PT1255535E (pt) 2006-09-29
AU2421601A (en) 2001-07-09
BG106952A (en) 2003-03-31
EE200200368A (et) 2003-10-15
DK1255535T3 (da) 2006-08-28
UA76411C2 (en) 2006-08-15
EA200200720A1 (ru) 2003-02-27
JP2003518486A (ja) 2003-06-10
CY1106127T1 (el) 2011-06-08
CA2397942A1 (en) 2001-07-05
GEP20053532B (en) 2005-05-25
PL208096B1 (pl) 2011-03-31
LT5033B (lt) 2003-07-25
CA2397942C (en) 2008-07-15
BG65713B1 (bg) 2009-08-31
PL357680A1 (en) 2004-07-26

Similar Documents

Publication Publication Date Title
BRPI0015567B8 (pt) composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica
CY1106127T1 (el) Φαρμακευτικη συσταση ελεγχομενης αποδεσμευσης που πepιεχει υδροχλωρικη τραμαδολη
ES2194732T3 (es) Composiciones farmaceuticas orales de liberacion controlada de mesalazina.
WO2005063218A3 (en) Pharmaceutical formulations of bisphosphonates
HK1096034A1 (en) A solid dosage form comprising a fibrate
NZ311145A (en) Controlled release formulations containing a poorly soluble drug in a solid dispersion with a hydrophilic poloxamer
BR0209320A (pt) ésteres de uridina farmaceuticamente ativos
YU76503A (sh) Farmaceutski aktivni estri uridina
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
DE69314186T2 (de) Brausemischungen enthaltend ibuprofen und verfahren
HK1054697A1 (en) Pharmaceutical preparations
UA66812C2 (uk) Препаративна форма лікарського засобу із регульованим вивільненням активної речовини
UY26303A1 (es) Composiciones farmacéuticas para administración oral y tópica
IT1284604B1 (it) Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
ATE212840T1 (de) Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung
WO2006064321A3 (en) Controlled release compositions of divalproex sodium
WO2006011001A3 (en) Controlled release compositions of divalproex sodium
HUP9902179A2 (hu) Hatóanyagként cisapridot tartalmazó PH-tól független, azonnali hatóanyag felszabadításra alkalmas szilárd gyógyszerkészítmény
AU2003219641A1 (en) Analgesical oral composition with controlled release of an opioid

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee